Siegrist Jonathan Philip has filed 10 insider transactions across 1 company since January 2025.
Most recent transaction: a grant/award of 36152 shares of QuidelOrtho Corp ($QDEL) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Restricted Stock Units | 36152 | $0.00 | 36,152.0000 | 67,931,540 | 9999.99% | 0.05% |
| Jan. 30, 2026 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Non-Qualified Stock Options | 36150 | $0.00 | 36,150.0000 | 67,931,540 | 9999.99% | 0.05% |
| Jan. 29, 2026 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Common Stock | 2448 | $0.00 | 14,428.0000 | 67,931,540 | 20.43% | 0.00% |
| Jan. 29, 2026 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | F | Common Stock | 1009 | $27.41 | 13,419.0000 | 67,931,540 | 6.99% | 0.00% |
| Jan. 29, 2026 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | M | Restricted Stock Units | 2448 | $0.00 | 4,898.0000 | 67,931,540 | 33.32% | 0.00% |
| Oct. 15, 2025 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Common Stock | 18656 | $0.00 | 18,656.0000 | 68,000,000 | 9999.99% | 0.03% |
| Oct. 15, 2025 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | F | Common Stock | 6676 | $27.31 | 11,980.0000 | 68,000,000 | 35.78% | 0.01% |
| Oct. 15, 2025 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | M | Restricted Stock Units | 18656 | $0.00 | 37,314.0000 | 68,000,000 | 33.33% | 0.03% |
| Jan. 29, 2025 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Restricted Stock Units | 7346 | $0.00 | 7,346.0000 | 67,200,000 | 9999.99% | 0.01% |
| Jan. 29, 2025 | QuidelOrtho Corp | $QDEL | Siegrist Jonathan Philip | EVP of R&D & CTO | A | Non-Qualified Stock Options | 7347 | $0.00 | 7,347.0000 | 67,200,000 | 9999.99% | 0.01% |